CompletedPhase 2NCT00459615

Phase II Dose Ranging Study of Artesunate

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
U.S. Army Office of the Surgeon General
Principal Investigator
Mark Polhemus, MD
USAMRU-K
Intervention
Artesunate for Injection(drug)
Enrollment
120 target
Eligibility
12-65 years · All sexes
Timeline
20072008

Study locations (2)

Collaborators

Military Infectious Diseases Research Program (MIDRP) · U.S. Army Medical Research and Development Command

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00459615 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials